{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:49:29Z","timestamp":1772120969645,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000983","name":"Mary Kay Ash Foundation","doi-asserted-by":"publisher","award":["P30CA062203"],"award-info":[{"award-number":["P30CA062203"]}],"id":[{"id":"10.13039\/100000983","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016953","name":"Comprehensive Cancer Center, University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A6A3A14039681"],"award-info":[{"award-number":["2021R1A6A3A14039681"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["TS200022"],"award-info":[{"award-number":["TS200022"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K22CA234399"],"award-info":[{"award-number":["K22CA234399"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AA029124"],"award-info":[{"award-number":["R01AA029124"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jbc.2023.105175","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T02:41:59Z","timestamp":1692412919000},"page":"105175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["MAPK13 stabilization via m6A mRNA modification limits anticancer efficacy of rapamycin"],"prefix":"10.1016","volume":"299","author":[{"given":"Joohwan","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujin","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7182-1859","authenticated-orcid":false,"given":"Cuauhtemoc B.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren A.","family":"Hoffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunhee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9914-8480","authenticated-orcid":false,"given":"Ki-Hong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3912-4820","authenticated-orcid":false,"given":"Varvara I.","family":"Rubtsova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6651-4213","authenticated-orcid":false,"given":"Cholsoon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8120-9169","authenticated-orcid":false,"given":"Gina","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2023.105175_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrg3724","article-title":"Gene expression regulation mediated through reversible m6A RNA methylation","volume":"15","author":"Fu","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jbc.2023.105175_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrg.2016.47","article-title":"RNA modifications: what have we learned and where are we headed?","volume":"17","author":"Frye","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jbc.2023.105175_bib3","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","article-title":"Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells","volume":"71","author":"Desrosiers","year":"1974","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.105175_bib4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12033-020-00269-5","article-title":"m6a RNA methylation: ramifications for gene expression and human health","volume":"62","author":"Karthiya","year":"2020","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.jbc.2023.105175_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"m6A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2023.105175_bib6","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2019 UTRs and near stop codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105175_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105175_bib8","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","article-title":"A\u00a0unified model for the function of YTHDF proteins in regulating m6A-modified mRNA","volume":"181","author":"Zaccara","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105175_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tig.2019.12.007","article-title":"Molecular mechanisms driving mRNA degradation by m6A modification","volume":"36","author":"Lee","year":"2020","journal-title":"Trends Genet."},{"key":"10.1016\/j.jbc.2023.105175_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/obr.12942","article-title":"Emerging role of m6 A RNA methylation in nutritional physiology and metabolism","volume":"21","author":"Wu","year":"2020","journal-title":"Obes. Rev."},{"key":"10.1016\/j.jbc.2023.105175_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","article-title":"The potential role of RNA N6-methyladenosine in cancer progression","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2023.105175_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13073-016-0395-8","article-title":"Emerging links between m6A and misregulated mRNA methylation in cancer","volume":"9","author":"Jaffrey","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.jbc.2023.105175_bib13","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.4416","article-title":"The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2023.105175_bib14","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","article-title":"m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer","volume":"20","author":"Liu","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2023.105175_bib15","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1038\/onc.2009.352","article-title":"Common corruption of the mTOR signaling network in human tumors","volume":"27","author":"Menon","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2023.105175_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.jbc.2023.105175_bib17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","article-title":"mTOR signalling and cellular metabolism are mutual determinants in cancer","volume":"18","author":"Mossmann","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2023.105175_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41556-018-0205-1","article-title":"mTOR as a central hub of nutrient signalling and cell growth","volume":"21","author":"Kim","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2023.105175_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2023.105175_bib20","doi-asserted-by":"crossref","first-page":"22583","DOI":"10.1074\/jbc.R114.566091","article-title":"Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR)","volume":"289","author":"Foster","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.105175_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2023.105175_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ncponc1112","article-title":"Rapamycin treatment for a child with germline PTEN mutation","volume":"5","author":"Marsh","year":"2008","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.jbc.2023.105175_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: one drug, many effects","volume":"19","author":"Li","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2023.105175_bib24","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.molcel.2021.03.010","article-title":"mTORC1 promotes cell growth via m6A-dependent mRNA degradation","volume":"81","author":"Cho","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2023.105175_bib25","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021945118","article-title":"mTORC1-chaperonin CCT signaling regulates m6A RNA methylation to suppress autophagy","volume":"118","author":"Tang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.105175_bib26","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.molcel.2021.03.009","article-title":"mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis","volume":"81","author":"Villa","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2023.105175_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.14348\/molcells.2022.0017","article-title":"m6a in the signal transduction network","volume":"45","author":"Jang","year":"2022","journal-title":"Mol. Cells"},{"key":"10.1016\/j.jbc.2023.105175_bib28","doi-asserted-by":"crossref","first-page":"L694","DOI":"10.1152\/ajplung.00204.2003","article-title":"Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways","volume":"286","author":"Yu","year":"2004","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.jbc.2023.105175_bib29","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1073\/pnas.0810790106","article-title":"Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells","volume":"106","author":"Yu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.105175_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2119\/2006-00070.Lim","article-title":"Expression of the neural stem cell markers NG2 and L1 in human angiomyolipoma: are angiomyolipomas neoplasms of stem cells?","volume":"13","author":"Lim","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.jbc.2023.105175_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.852859","article-title":"Chemical biology screening identifies a vulnerability to checkpoint kinase inhibitors in TSC2-deficient renal angiomyolipomas","volume":"12","author":"Vaughan","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2023.105175_bib32","doi-asserted-by":"crossref","first-page":"R609","DOI":"10.1186\/bcr1262","article-title":"Somatic mutation and gain of copy number of PIK3CA in human breast cancer","volume":"7","author":"Wu","year":"2005","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jbc.2023.105175_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102809","article-title":"Exploiting chromosomal instability of PTEN-deficient triple-negative breast cancer cell lines for the sensitization against PARP1 inhibition in a replication-dependent manner","volume":"12","author":"Rieckhoff","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2023.105175_bib34","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jbc.2023.105175_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/acel.12313","article-title":"Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins","volume":"14","author":"Schreiber","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.jbc.2023.105175_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2023.105175_bib37","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1158\/1535-7163.MCT-14-0330","article-title":"Suppression of feedback loops mediated by PI3K\/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance","volume":"13","author":"Rozengurt","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2023.105175_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.570586","article-title":"Functions of p38 MAP kinases in the central nervous system","volume":"13","author":"Asih","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jbc.2023.105175_bib39","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3390\/cancers13092077","article-title":"A\u00a0special view of what was almost forgotten: P38\u03b4 MAPK","volume":"13","author":"Anton","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2023.105175_bib40","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/ijc.24944","article-title":"p38delta\/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion","volume":"126","author":"Tan","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2023.105175_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fcell.2016.00031","article-title":"p38\u03b3 and p38\u03b4 mitogen activated protein kinases (MAPKs), new stars in the MAPK galaxy","volume":"4","author":"Esc\u00f3s","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2023.105175_bib42","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/emboj\/19.6.1301","article-title":"Molecular determinants that mediate selective activation of p38 MAP kinase isoforms","volume":"19","author":"Enslen","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2023.105175_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101445","article-title":"A\u00a0stress response p38 MAP kinase inhibitor SB202190 promoted TFEB\/TFE3-dependent autophagy and lysosomal biogenesis independent of p38","volume":"32","author":"Yang","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.jbc.2023.105175_bib44","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1101\/gad.269415.115","article-title":"A\u00a0majority of m6A residues are in the last exons, allowing the potential for 3\u2019 UTR regulation","volume":"29","author":"Ke","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2023.105175_bib45","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.molcel.2019.09.032","article-title":"Landscape and regulation of m6A and m6Am methylome across human and mouse tissues","volume":"77","author":"Liu","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2023.105175_bib46","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.molcel.2019.02.034","article-title":"Endoribonucleolytic cleavage of m6A-containing RNAs by RNase P\/MRP complex","volume":"74","author":"Park","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2023.105175_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12626","article-title":"YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex","volume":"7","author":"Du","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.105175_bib48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1101\/gad.3.1.60","article-title":"The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways","volume":"3","author":"Shyu","year":"1989","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2023.105175_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbior.2014.04.003","article-title":"Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles","volume":"55","author":"Kenney","year":"2014","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbc.2023.105175_bib50","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1432-1033.1990.tb19169.x","article-title":"Functional properties of phosphorylated elongation factor 2","volume":"191","author":"Carlberg","year":"1990","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jbc.2023.105175_bib51","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1093\/emboj\/20.16.4360","article-title":"A\u00a0novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4\/p38delta","volume":"20","author":"Knebel","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2023.105175_bib52","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/emboj.2008.39","article-title":"cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner","volume":"27","author":"Smith","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2023.105175_bib53","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1093\/emboj\/20.16.4370","article-title":"Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase","volume":"20","author":"Wang","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2023.105175_bib54","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.bbagen.2016.06.023","article-title":"First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes","volume":"1860","author":"Yurtsever","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2023.105175_bib55","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","article-title":"The global phosphorylation Landscape of SARS-CoV-2 infection","volume":"182","author":"Bouhaddou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105175_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aad5111","article-title":"Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors","volume":"8","author":"Hsieh","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2023.105175_bib57","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1042\/BCJ20190958","article-title":"Small molecule H89 renders the phosphorylation of S6K1 and AKT resistant to mTOR inhibitors","volume":"477","author":"Melick","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2023.105175_bib58","first-page":"3065","article-title":"Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer","volume":"118","author":"Carracedo","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2023.105175_bib59","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jbc.2023.105175_bib60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13023-020-01490-w","article-title":"Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex","volume":"15","author":"Lu","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jbc.2023.105175_bib61","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.celrep.2015.07.045","article-title":"Amino acid activation of mTORC1 by a PB1-domain-driven kinase complex cascade","volume":"12","author":"Linares","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2023.105175_bib62","doi-asserted-by":"crossref","first-page":"30122","DOI":"10.1074\/jbc.272.48.30122","article-title":"Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta","volume":"272","author":"Jiang","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.105175_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jbc.2023.105175_bib64","first-page":"6774","article-title":"circTNFRSF21, a newly identified circular RNA promotes endometrial carcinoma pathogenesis through regulating miR-1227-MAPK13\/ATF2 axis","volume":"12","author":"Liu","year":"2020","journal-title":"Aging (Albany N.Y.)"},{"key":"10.1016\/j.jbc.2023.105175_bib65","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/1541-7786.MCR-13-0258-T","article-title":"Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide","volume":"12","author":"Parkhitko","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2023.105175_bib66","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1038\/s41467-022-32673-7","article-title":"Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment","volume":"13","author":"Tang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.105175_bib67","doi-asserted-by":"crossref","first-page":"L1447","DOI":"10.1152\/ajplung.00262.2015","article-title":"Pharmacological targeting of VEGFR signaling with axitinib inhibits Tsc2-null lesion growth in the mouse model of lymphangioleiomyomatosis","volume":"309","author":"Atochina-Vasserman","year":"2015","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823022032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823022032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:38:10Z","timestamp":1762187890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925823022032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0021925823022032"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2023.105175","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.08.05.502726","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MAPK13 stabilization via m6A mRNA modification limits anticancer efficacy of rapamycin","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2023.105175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"105175"}}